ABOUT ABBV-744 AS A POTENTIAL THERAPEUTIC OPTION FOR AGGRESSIVE CANCERS

Added studies in progress propose that ARV-825 might also be effective in enhancing the reaction to estrogen deprivation (aromatase inhibition), another element of standard of treatment in ER+ breast cancer.Celastrol was recognized being a Myb inhibitor that suppressed C/EBPβ action and repressed AML cell proliferation in a very primary mouse prod